SCHEMBL1015853

SCHEMBL1015853

CCNc1cc(-c2ccc(F)cc2)ccc1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.53
TSHR P16473 1/20 0.53
RECQL P46063 1/20 0.53
TNKS2 Q9H2K2 1/20 0.38
BRD4 O60885 1/20 0.38
MAPT P10636 4/20 0.38
ALDH1A1 P00352 3/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
TDP1 Q9NUW8 1/20 0.36
KIT P10721 1/20 0.36
HDAC2 Q92769 2/20 0.36
HDAC1 Q13547 1/20 0.36
KDM4E B2RXH2 2/20 0.35
TP53 P04637 1/20 0.35
NPC1 O15118 1/20 0.34
HTT P42858 1/20 0.34
RAB9A P51151 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HDAC8 Q9BY41 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1643707 0.85 CYP3A4 (0.60) CYP3A4TSHRRECQLMAPTALDH1A1
SCHEMBL27925196 0.82 CYP3A4 (0.73) CYP3A4TSHRRECQLKMT2AMEN1
SCHEMBL1015114 0.81 MAPK14 (0.41) CYP3A4TSHRRECQLTNKS2MAPT
SCHEMBL21020941 0.79 TNKS2 (0.41) TNKS2MAPTALDH1A1KMT2AHDAC2
SCHEMBL16588352 0.79 FLT3 (0.58)
SCHEMBL1015415 0.75 CYP3A4 (0.49) CYP3A4TSHRRECQLMAPTALDH1A1
SCHEMBL880841 0.73 ALDH1A1 (0.51) CYP3A4TSHRRECQLMAPTALDH1A1
SCHEMBL3091856 0.72 LMNA (0.47) MAPTALDH1A1KMT2AMEN1KDM4E
SCHEMBL2499765 0.72 CYP3A4 (0.64) CYP3A4TSHRRECQLBRD4MAPT
SCHEMBL3916722 0.72 QPCT (0.53) CYP3A4TSHRRECQLMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 CYP3A4 2543/4885TSHR 2763/4885RECQL 2411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.